Page last updated: 2024-09-04

fusidic acid and Disease Models, Animal

fusidic acid has been researched along with Disease Models, Animal in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19904 (19.05)18.7374
1990's4 (19.05)18.2507
2000's3 (14.29)29.6817
2010's8 (38.10)24.3611
2020's2 (9.52)2.80

Authors

AuthorsStudies
Andersson, DI; Maisnier-Patin, S; Paulander, W; Pennhag, A1
Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO1
Dai, M; Kyei-Baffour, K; Mohammad, H; Seleem, MN1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Chibale, K; Dziwornu, GA; Kaur, G; Okombo, J; Strydom, N; Wiesner, L1
Agrawal, N; Govender, T; Kalhapure, RS; Mocktar, C; Omolo, CA; Rambharose, S1
Abutaleb, NS; Dai, M; Kyei-Baffour, K; Mohammad, H; Seleem, MN1
Knoll, LJ; Neal, LM; Payne, AJ1
Chen, DX; Li, XG; Liang, GY; Liu, RM; Xiao, JH; Zhang, LT; Zhang, Y; Zhong, JJ1
Baude, J; Bès, M; Campergue, JB; Fischer, A; François, P; Imbert, PR; Laurent, F; Lina, G; Louche, A; Martins Simões, P; Nijland, R; Patot, S; Salcedo, SP; Schrenzel, J; Tristan, A; Vandenesch, F1
Baie, S; Febriyenti, F; Laila, L; Salhimi, SM1
Bendtzen, K; Buschard, K; Di Marco, R; Mangano, K; Musumeci, R; Nicoletti, F; Papaccio, G; Quattrocchi, C; Speciale, AM1
Bayarslan, C; Coskun, B; Ersoz, G; Eskandari, MM; Kaya, A; Oztuna, V1
Bergholm, AM; Henning, C; Holm, SE1
Bendtzen, K; Di Marco, R; Grasso, S; Magro, G; Meroni, PL; Morrone, S; Nicoletti, F; Santoni, A; Tempera, G; Zaccone, P1
Aubert, JP; Magalon, G1
Bendtzen, K; Cusumano, V; Cuzzola, M; Genovese, F; Mancuso, G; Nicoletti, F; Teti, G1
Benfeldt, E; Groth, L1
Hamilton-Miller, JM1
Hirst, RG; Olds, RJ1
Elson, RA; Jephcott, AE; McGechie, DB; Verettas, D1

Reviews

1 review(s) available for fusidic acid and Disease Models, Animal

ArticleYear
Antimicrobial agents acting against anaerobes.
    The Journal of antimicrobial chemotherapy, 1975, Volume: 1, Issue:3

    Topics: Aminoglycosides; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Clindamycin; Colistin; Disease Models, Animal; Erythromycin; Fusidic Acid; Humans; Lactams; Lincomycin; Microbial Sensitivity Tests; Nitrofurans; Nitroimidazoles; Polymyxins; Rifamycins; Sulfamethoxazole; Tetracyclines; Trimethoprim; Vancomycin

1975

Trials

1 trial(s) available for fusidic acid and Disease Models, Animal

ArticleYear
Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration.
    Acta dermato-venereologica, 1998, Volume: 78, Issue:4

    Topics: Administration, Oral; Administration, Topical; Adult; Animals; Betamethasone; Cell Membrane Permeability; Chromatography, High Pressure Liquid; Disease Models, Animal; Feasibility Studies; Female; Fusidic Acid; Humans; Male; Microdialysis; Patch Tests; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Skin; Skin Absorption; Sodium Dodecyl Sulfate; Surface-Active Agents

1998

Other Studies

19 other study(ies) available for fusidic acid and Disease Models, Animal

ArticleYear
Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Animals; Caenorhabditis elegans; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Mice; Salmonella Infections, Animal; Salmonella typhimurium

2007
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
    European journal of medicinal chemistry, 2018, Jul-15, Volume: 155

    Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Methicillin; Mice; Microbial Sensitivity Tests; Molecular Structure; Skin Diseases, Bacterial; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Wound Infection

2018
Second-generation aryl isonitrile compounds targeting multidrug-resistant Staphylococcus aureus.
    Bioorganic & medicinal chemistry, 2019, 05-01, Volume: 27, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Disease Models, Animal; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nitriles; Skin Diseases; Staphylococcal Infections

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Pharmacokinetics and Organ Distribution of C-3 Alkyl Esters as Potential Antimycobacterial Prodrugs of Fusidic Acid.
    ACS infectious diseases, 2020, 03-13, Volume: 6, Issue:3

    Topics: Alkylation; Animals; Anti-Bacterial Agents; Disease Models, Animal; Esters; Fusidic Acid; Male; Mice; Mice, Inbred C57BL; Prodrugs

2020
Formulation and Molecular Dynamics Simulations of a Fusidic Acid Nanosuspension for Simultaneously Enhancing Solubility and Antibacterial Activity.
    Molecular pharmaceutics, 2018, 08-06, Volume: 15, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Fusidic Acid; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Nanoparticles; Particle Size; Poloxamer; Solubility; Staphylococcal Skin Infections

2018
An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection.
    Journal of global antimicrobial resistance, 2019, Volume: 19

    Topics: Animals; Anti-Bacterial Agents; Caco-2 Cells; Disease Models, Animal; Female; Fusidic Acid; Humans; Keratinocytes; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microsomes, Liver; Nitriles; Rifampin; Skin; Staphylococcal Infections; Staphylococcal Skin Infections

2019
Fusidic acid is an effective treatment against Toxoplasma gondii and Listeria monocytogenes in vitro, but not in mice.
    Parasitology research, 2013, Volume: 112, Issue:11

    Topics: Animal Structures; Animals; Anti-Infective Agents; Colony Count, Microbial; Disease Models, Animal; Fusidic Acid; Listeria monocytogenes; Listeriosis; Mice; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Plasmodium falciparum; Survival Analysis; Toxoplasma; Toxoplasmosis, Animal; Treatment Failure

2013
Synergistic antitumor efficacy of antibacterial helvolic acid from Cordyceps taii and cyclophosphamide in a tumor mouse model.
    Experimental biology and medicine (Maywood, N.J.), 2017, Volume: 242, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Cell Line, Tumor; Cordyceps; Cyclin D1; Cyclophosphamide; Disease Models, Animal; Drug Synergism; Fusidic Acid; Male; Mice; Proliferating Cell Nuclear Antigen; Sarcoma; Wnt Proteins; Wnt Signaling Pathway

2017
The TIR Homologue Lies near Resistance Genes in Staphylococcus aureus, Coupling Modulation of Virulence and Antimicrobial Susceptibility.
    PLoS pathogens, 2017, Volume: 13, Issue:1

    Topics: Animals; Bacterial Proteins; Cell Line; Disease Models, Animal; Fusidic Acid; HEK293 Cells; Humans; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Neutrophils; Penicillin-Binding Proteins; Receptors, Interleukin-1; Signal Transduction; Staphylococcal Skin Infections; Staphylococcus aureus; Toll-Like Receptors; Virulence Factors

2017
Wound healing effect of Haruan (Channa striatus) spray.
    International wound journal, 2011, Volume: 8, Issue:5

    Topics: Administration, Topical; Aerosols; Animals; Burns; Disease Models, Animal; Elasticity; Fusidic Acid; Mice; Rabbits; Rats; Rats, Sprague-Dawley; Skin; Treatment Outcome; Wound Healing

2011
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats.
    Clinical immunology (Orlando, Fla.), 2003, Volume: 109, Issue:3

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Benzenesulfonates; Colitis, Ulcerative; Disease Models, Animal; Fusidic Acid; Histocytochemistry; Interferon-gamma; Male; Rats; Rats, Inbred Lew; Tumor Necrosis Factor-alpha; Weight Loss

2003
Addition of fusidic acid impregnated bone cement to systemic teicoplanin therapy in the treatment of rat osteomyelitis.
    Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bone Cements; Disease Models, Animal; Foreign-Body Reaction; Fusidic Acid; Methicillin Resistance; Osteomyelitis; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Teicoplanin; Tibia

2004
Static and dynamic properties of tissue cage fluid in rabbits.
    European journal of clinical microbiology, 1984, Volume: 3, Issue:2

    Topics: Albumins; Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Proteins; Body Fluids; Counterimmunoelectrophoresis; Disease Models, Animal; Fusidic Acid; Protein Binding; Rabbits; Sucrose

1984
Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.
    Immunology, 1995, Volume: 85, Issue:4

    Topics: Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Enterotoxins; Female; Fusidic Acid; Hyperglycemia; Interferon-gamma; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Shock, Septic; Tumor Necrosis Factor-alpha

1995
[Silastic gel and elastomer in the cicatrization of wounds in the rabbit].
    Journal de chirurgie, 1993, Volume: 130, Issue:12

    Topics: Animals; Deoxyribonucleases; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Female; Fibrinolysin; Fluocinonide; Fusidic Acid; Gels; Rabbits; Silicone Elastomers; Wound Healing

1993
Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Fusidic Acid; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Shock, Septic; Tumor Necrosis Factor-alpha

1996
Corynebacterium kutscheri and its alleged avirulent variant in mice.
    The Journal of hygiene, 1978, Volume: 80, Issue:3

    Topics: Animals; Bacterial Vaccines; Corynebacterium; Corynebacterium Infections; Disease Models, Animal; Drug Resistance, Microbial; Female; Fusidic Acid; Hydrocortisone; Hysterectomy; Immunity, Innate; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pregnancy; Streptomycin; Virulence

1978
Bacterial infection and acrylic cement in the rat.
    The Journal of bone and joint surgery. British volume, 1977, Volume: 59-B, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bone Cements; Bone Diseases; Disease Models, Animal; Fusidic Acid; Gentamicins; Rats; Staphylococcal Infections

1977